These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Lack of Parkin Anticipates the Phenotype and Affects Mitochondrial Morphology and mtDNA Levels in a Mouse Model of Parkinson's Disease. Pinto M; Nissanka N; Moraes CT J Neurosci; 2018 Jan; 38(4):1042-1053. PubMed ID: 29222404 [No Abstract] [Full Text] [Related]
4. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms. Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809 [TBL] [Abstract][Full Text] [Related]
7. The Absence of Parkin Does Not Promote Dopamine or Mitochondrial Dysfunction in PolgA Scott L; Karuppagounder SS; Neifert S; Kang BG; Wang H; Dawson VL; Dawson TM J Neurosci; 2022 Dec; 42(49):9263-9277. PubMed ID: 36280265 [TBL] [Abstract][Full Text] [Related]
8. Severe nigrostriatal degeneration without clinical parkinsonism in patients with polymerase gamma mutations. Tzoulis C; Tran GT; Schwarzlmüller T; Specht K; Haugarvoll K; Balafkan N; Lilleng PK; Miletic H; Biermann M; Bindoff LA Brain; 2013 Aug; 136(Pt 8):2393-404. PubMed ID: 23625061 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of parkin ameliorates dopaminergic neurodegeneration induced by 1- methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Bian M; Liu J; Hong X; Yu M; Huang Y; Sheng Z; Fei J; Huang F PLoS One; 2012; 7(6):e39953. PubMed ID: 22792139 [TBL] [Abstract][Full Text] [Related]
10. Mesencephalic complex I deficiency does not correlate with parkinsonism in mitochondrial DNA maintenance disorders. Palin EJ; Paetau A; Suomalainen A Brain; 2013 Aug; 136(Pt 8):2379-92. PubMed ID: 23811324 [TBL] [Abstract][Full Text] [Related]
11. Dysregulation of parkin in the substantia nigra of db/db and high-fat diet mice. Khang R; Park C; Shin JH Neuroscience; 2015 May; 294():182-92. PubMed ID: 25779963 [TBL] [Abstract][Full Text] [Related]
12. Progressive parkinsonism due to mitochondrial impairment: Lessons from the MitoPark mouse model. Beckstead MJ; Howell RD Exp Neurol; 2021 Jul; 341():113707. PubMed ID: 33753138 [TBL] [Abstract][Full Text] [Related]
14. MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity. Thomas B; von Coelln R; Mandir AS; Trinkaus DB; Farah MH; Leong Lim K; Calingasan NY; Flint Beal M; Dawson VL; Dawson TM Neurobiol Dis; 2007 May; 26(2):312-22. PubMed ID: 17336077 [TBL] [Abstract][Full Text] [Related]
15. Increased mitochondrial DNA deletions in substantia nigra dopamine neurons of the aged rat. Parkinson GM; Dayas CV; Smith DW Curr Aging Sci; 2014; 7(3):155-60. PubMed ID: 25612740 [TBL] [Abstract][Full Text] [Related]
17. SLP-2 interacts with Parkin in mitochondria and prevents mitochondrial dysfunction in Parkin-deficient human iPSC-derived neurons and Drosophila. Zanon A; Kalvakuri S; Rakovic A; Foco L; Guida M; Schwienbacher C; Serafin A; Rudolph F; Trilck M; Grünewald A; Stanslowsky N; Wegner F; Giorgio V; Lavdas AA; Bodmer R; Pramstaller PP; Klein C; Hicks AA; Pichler I; Seibler P Hum Mol Genet; 2017 Jul; 26(13):2412-2425. PubMed ID: 28379402 [TBL] [Abstract][Full Text] [Related]
18. Detrimental effects of oxidative losses in parkin activity in a model of sporadic Parkinson's disease are attenuated by restoration of PGC1alpha. Siddiqui A; Rane A; Rajagopalan S; Chinta SJ; Andersen JK Neurobiol Dis; 2016 Sep; 93():115-20. PubMed ID: 27185595 [TBL] [Abstract][Full Text] [Related]
19. Mitochondrial DNA deletions/rearrangements in parkinson disease and related neurodegenerative disorders. Gu G; Reyes PE; Golden GT; Woltjer RL; Hulette C; Montine TJ; Zhang J J Neuropathol Exp Neurol; 2002 Jul; 61(7):634-9. PubMed ID: 12125742 [TBL] [Abstract][Full Text] [Related]